| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.0066 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.0063 | 1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.0049 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |